These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8693538)

  • 1. Alloantibody and intragraft cellular response to MHC class I-disparate kidney allografts in recipients tolerized by donor-specific transfusion and cyclosporine.
    Tweedle JR; Middleton SE; Marshall HE; Bradley JA; Bolton EM
    Transplantation; 1996 Jul; 62(1):23-9. PubMed ID: 8693538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
    Yang CP; Shittu E; Bell EB
    J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity.
    Gracie JA; Bolton EM; Porteous C; Bradley JA
    J Exp Med; 1990 Dec; 172(6):1547-57. PubMed ID: 2258695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection.
    Yang CP; Shittu E; McManus B; Wood PJ; Bell EB
    Transplantation; 1998 Sep; 66(5):639-45. PubMed ID: 9753346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
    Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP
    Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
    Wasowska B; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.
    Morton AL; Bell EB; Bolton EM; Marshall HE; Roadknight C; McDonagh M; Bradley JA
    Eur J Immunol; 1993 Sep; 23(9):2078-84. PubMed ID: 8103742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. I. Correlation of graft survival with antidonor IgG antibody subclasses.
    Mhoyan A; Cramer DV; Baquerizo A; Shirwan H
    Transplantation; 1997 Dec; 64(12):1665-70. PubMed ID: 9422399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1993 May; 55(5):1132-8. PubMed ID: 8497894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity.
    Yamamoto S; Ito T; Nakata S; Nozaki S; Uchikoshi F; Shirakura R; Kamiike W; Miyata M; Matsuda H
    Transplantation; 1994 Apr; 57(8):1217-22. PubMed ID: 7909966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
    Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
    J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different patterns of donor MHC antigen induction in rat kidney allografts following active and passive enhancement.
    Priestley CA; Fabre JW
    Transplantation; 1989 Aug; 48(2):275-80. PubMed ID: 2667211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
    Goggins WC; Fisher RA; Dattilo JB; Cohen DS; Tawes JW; Dattilo MP; Babcock GF; Frede SE; Wakely PE; Posner MP
    Transplantation; 1997 Jan; 63(2):310-4. PubMed ID: 9020336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.